跳至主要内容
临床试验/2024-513163-57-00
2024-513163-57-00招募中2 期

Permanence of Indocyanine Green in axillary lymph nodes three weeks after subdermal injection in patients with Breast Carcinoma and metastatic lymph nodes: The FLUO Trial

Centro Di Riferimento Oncologico Di Aviano1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2024年10月11日最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
招募中
入组人数
10
试验地点
1
主要终点
Frequency of patient with at least 3 fluorescent lymph nodes

研究概览

简要总结

Permanence of fluorescence at the level of axillary lymph nodes at 2-3 weeks after subcutaneous injection of Indocyanine Green (2.5 mg), in patients who will undergo radical axillary surgery [Time Frame: up to 3 weeks]

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 years 至 65+ years(18-64 Years, 65+ Years)
性别
Female
接受健康志愿者

入选标准

  • Written informed consent prior to beginning any protocol specific procedure during treatment and follow up, according to regulatory requirements.
  • Age equal to or higher than 18 years
  • Patients affeted by breast cancer with cyto-histological confirmation of lymph node metastases and eligible for quadrantectomy/mastectomy combined with radical axillary surgery.

排除标准

  • Allergy to iodium or Indocyanine Green
  • Presence of Thyroid disorders (hyperthyroidism, autoimmune thyroid adenomas)
  • Patients not eligible for radical axillary surgery
  • Patient in a state of pregnancy
  • Under the age of 18 years
  • Non-autonomous patient or in need of a legal representative

结局指标

主要结局

Frequency of patient with at least 3 fluorescent lymph nodes

Frequency of patient with at least 3 fluorescent lymph nodes

次要结局

  • Absolute frequency of total number of fluorescent lymph nodes per patient
  • Absolute frequency of lymph nodes in group A and in group B
  • Frequency of lymph nodes with metastases resulting fluorescent
  • Frequency of fluorescent and non-fluorescent lymph nodes between subgroups of patients with different demographic and clinical characteristics

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Stefano Fracon

Scientific

Centro Di Riferimento Oncologico Di Aviano

研究点 (1)

Loading locations...

相似试验